Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Other Related Information Mapping in Human Pancreatic Cancer Tissue by GLP-1 (7-36)-amide Antibody (H-028-11) Protocol for antibody staining Tissue Sample Human pancreas cancer tissues Fixative 10% formalin Embedding Paraffin Negative Control No primary antibody Pretreatment N/A Blocking 3% H2O2, 2% Normal Goat Serum Primary Antibody Rabbit Anti-GLP-1 (7-36)-NH2 Antiserum (Catalog No.: H-028-11) Optimal Dilution 1: 500 Secondary Antibody Goat Anti-Rabbit IgG, Biotinylated (1:400), 30 min Amplification Streptavidin-HRP (Vector), 1:400, 30 min Detection System HRP Substrate DAB (Sigma), 3 min Counterstained Hematoxylin, 30 sec Mapping in Rat Pancreas and Intestines by GLP-1 (7-37) Antibody (H-028-13) Rat Pancreatic and intestinal tissue Pre-immuno serum Intact 2% Normal Goat Serum Rabbit Anti-GLP-1 (7-37) (Human, Rat, Mouse, Porcine) Serum (Catalog No.:H-028-13) 1:500, 1 hour at RT ABC (Vector) (1:400, 30 min) with methyl green Rat pancreatic and intestinal sections with an antiserum for human GLP-1 (737) (Phoenix Pharmaceuticals, Mountain View, California, USA) at a concentration of 1/500
Oxidative stress in vitiligo: photo-oxidation of pterins produces H(2)O(2) and pterin-6-carboxylic acid
Contact your doctor or seek emergency care for: severe persistent abdominal pain (pancreatitis), signs of gallbladder problems, a lump in your neck (thyroid warning), severe allergic reaction symptoms, or any side effects that are unmanageable or worsening over time
Employers should require members to participate in lifestyle or obesity coaching programs as part of their GLP-1 coverage
L2-Cmu plasma concentrations were measured using an ELISA method with an LLOQ of 0.1 g/mL and assay range of 0.120 g/mL
[PMID: 33750044] PubMed record related to this compound for laboratory literature review
